Vizient Urges the Current Administration to Enable Federal Officials from Across the Government to Begin Formal Engagement with Biden’s Transition Team

November 20, 2020

Vizient, Inc., the nation’s largest health care performance improvement company serving a diverse membership that includes academic medical centers, pediatric facilities, community hospitals, integrated health care delivery networks and non-acute health care providers, issued the following statement on the urgent need to allow the President-elect Biden’s transition team access to federal government efforts to combat the coronavirus:

Vizient believes the magnitude of the COVID-19 crisis requires a coordinated, wide-scale and continuous response from the federal government. We urge the current administration to enable federal officials from across the government to begin formal engagement with members of President-elect Biden’s transition team so that the ongoing response to combating the COVID-19 pandemic continues without interruption.”

Since the beginning of the pandemic, Vizient has worked closely with the current administration to help resolve supply chain issues and other challenges to support our member hospitals in their efforts to access essential medical supplies and equipment. It is important that steps the current administration has taken are seamlessly transitioned to the incoming administration’s plans. This transition is vital to meeting the needs of hospitals as they work to activate their COVID-19 case surge plans, procure essential medical supplies, and care for patients.

Of critical importance is information on the strategy to successfully launch a comprehensive and equitable vaccination distribution plan. Connecting current members of the administration with members of the incoming administration’s transition team would help guard against lapses in the national response moving forward. It would also help ensure that the current public/private partnership, that has been integral in the nation’s response thus far, can continue without interruption.

With so much hard work underway, and much that still needs to be done, Vizient urges the current administration to enable members of the President-elect Biden transition team to begin formal participation in the federal government’s COVID-19 planning.”

SourceVizient

Hot this week

Medtronic Expands AiBLE Spine Surgery Ecosystem with New Technologies and Siemens Healthineers Partnership

New advancements in the AiBLE Spine Surgery ecosystem build upon the company's commitment to procedural innovation and execution

Axlab, Danish Medtech Pioneer, expands to US with Advanced Robotic Tissue Sectioning for Pathology Laboratories

Kris Rokke, National Sales Director for Axlab in the US. "My team and I are extremely excited and honored about this unique opportunity to also offer this advanced technology to labs across the US and thus contribute to the pathology labs of tomorrow."

Spartan Medical Broadens Single-Use Sterile Instrument Portfolio to Improve Outcomes, Increase Efficiency, and Generate Cost Savings

Spartan Medical products portfolio of single-use, sterile med tech includes micro and minor surgical convenience kits, kerrison rongeurs, spinal and general surgical retractors, dural repair kits, synthetic biologics, and a wide range of orthopedic pre-sterilized implants and devices.

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.